Literature DB >> 22982874

Structural identification and cardiovascular activities of oxidized phospholipids.

Robert G Salomon1.   

Abstract

Free radical-induced oxidation of membrane phospholipids generates complex mixtures of oxidized phospholipids (oxPLs). The combinatorial operation of a few dozen reaction types on a few dozen phospholipid structures results in the production of a dauntingly vast diversity of oxPL molecular species. Structural identification of the individual oxPL in these mixtures is a redoubtable challenge that is absolutely essential to allow determination of the biological activities of individual species. With an emphasis on cardiovascular consequences, this Review focuses on biological activities of oxPLs whose molecular structures are known and highlights 2 diametrically opposite approaches that were used to determine those structures, that is, (1) the classic approach from bioactivity of a complex mixture to isolation and structural characterization of the active molecule followed by confirmation of the structure by unambiguous chemical synthesis and (2) hypothesis of products that are likely to be generated by lipid oxidation, followed by synthesis, and then detection in vivo guided by the availability of authentic standards, and last, characterization of biological activities. Especially important for the application of the second paradigm is the capability of LC-MS/MS and derivatizations to selectively detect and quantify specific oxPL in complex mixtures, without the need for their isolation or complete separation. This technology can provide strong evidence for identity by comparisons with pure, well-characterized samples available by chemical syntheses. Those pure samples are critical for determining the biological activities attributable to specific molecular species of oxPLs in the complex mixtures generated in vivo as a consequence of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982874      PMCID: PMC3518430          DOI: 10.1161/CIRCRESAHA.112.275388

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  74 in total

1.  Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.

Authors:  P L Smiley; K E Stremler; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

2.  Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal.

Authors:  L M Sayre; W Sha; G Xu; K Kaur; D Nadkarni; G Subbanagounder; R G Salomon
Journal:  Chem Res Toxicol       Date:  1996 Oct-Nov       Impact factor: 3.739

3.  Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein.

Authors:  A D Watson; G Subbanagounder; D S Welsbie; K F Faull; M Navab; M E Jung; A M Fogelman; J A Berliner
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

4.  Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol.

Authors:  S M Colles; K C Irwin; G M Chisolm
Journal:  J Lipid Res       Date:  1996-09       Impact factor: 5.922

5.  Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo.

Authors:  A D Watson; N Leitinger; M Navab; K F Faull; S Hörkkö; J L Witztum; W Palinski; D Schwenke; R G Salomon; W Sha; G Subbanagounder; A M Fogelman; J A Berliner
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

6.  (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins.

Authors:  K Kaur; R G Salomon; J O'Neil; H F Hoff
Journal:  Chem Res Toxicol       Date:  1997-12       Impact factor: 3.739

7.  Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid.

Authors:  G Hoppe; G Subbanagounder; J O'Neil; R G Salomon; H F Hoff
Journal:  Biochim Biophys Acta       Date:  1997-01-07

8.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Interferon-gamma selectively induces Rab5a synthesis and processing in mononuclear cells.

Authors:  C Alvarez-Dominguez; P D Stahl
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

10.  Apoptosis and related proteins in different stages of human atherosclerotic plaques.

Authors:  M M Kockx; G R De Meyer; J Muhring; W Jacob; H Bult; A G Herman
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

View more
  20 in total

1.  Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

Authors:  Xin Huang; Baoxin Liu; Yidong Wei; Ryan Beyea; Han Yan; Steven T Olson
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

Review 2.  Inflammation and oxidative stress in angiogenesis and vascular disease.

Authors:  Young-Woong Kim; Xiaoxia Z West; Tatiana V Byzova
Journal:  J Mol Med (Berl)       Date:  2013-02-22       Impact factor: 4.599

3.  Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE-/- mice and activate platelets via TLR2.

Authors:  Sudipta Biswas; Liang Xin; Soumya Panigrahi; Alejandro Zimman; Hua Wang; Valentin P Yakubenko; Tatiana V Byzova; Robert G Salomon; Eugene A Podrez
Journal:  Blood       Date:  2016-03-25       Impact factor: 22.113

Review 4.  Redox (phospho)lipidomics of signaling in inflammation and programmed cell death.

Authors:  Yulia Y Tyurina; Claudette M St Croix; Simon C Watkins; Alan M Watson; Michael W Epperly; Tamil S Anthonymuthu; Elena R Kisin; Irina I Vlasova; Olga Krysko; Dmitri V Krysko; Alexandr A Kapralov; Haider H Dar; Vladimir A Tyurin; Andrew A Amoscato; Elena N Popova; Sergey B Bolevich; Peter S Timashev; John A Kellum; Sally E Wenzel; Rama K Mallampalli; Joel S Greenberger; Hulya Bayir; Anna A Shvedova; Valerian E Kagan
Journal:  J Leukoc Biol       Date:  2019-05-09       Impact factor: 4.962

5.  Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis.

Authors:  Jianhong Lu; Shuyuan Guo; Xinli Xue; Qun Chen; Jing Ge; Yujuan Zhuo; Huiqin Zhong; Buxing Chen; Mingming Zhao; Wei Han; Takashi Suzuki; Mingjiang Zhu; Lin Xia; Claus Schneider; Timothy S Blackwell; Ned A Porter; Lemin Zheng; Sotirios Tsimikas; Huiyong Yin
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

Review 6.  An Insight into Recent Advances on Platelet Function in Health and Disease.

Authors:  Preeti Kumari Chaudhary; Sanggu Kim; Soochong Kim
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

7.  Carboxyethylpyrroles: From Hypothesis to the Discovery of Biologically Active Natural Products.

Authors:  Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2016-11-02       Impact factor: 3.739

8.  CEP Is an Important and Ubiquitous Oxidation Specific Epitope Recognized by Innate Pattern Recognition Receptors.

Authors:  Joseph L Witztum
Journal:  Circ Res       Date:  2015-07-31       Impact factor: 17.367

9.  Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.

Authors:  Detao Gao; Eugene A Podrez
Journal:  Free Radic Biol Med       Date:  2017-11-15       Impact factor: 7.376

Review 10.  Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

Authors:  Sean S Davies; Lilu Guo
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.